NCT06391918 2026-03-13
Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors
GenVivo, Inc.
Phase 1 Terminated
GenVivo, Inc.
BeOne Medicines
Adanate, Inc
Biosplice Therapeutics, Inc.
Georgetown University
Athenex, Inc.
Centre Hospitalier Universitaire Vaudois